INSUBCONTINENT EXCLUSIVE:
A sliver of hope has emerged from a potential dengue vaccine study, as this mosquito-borne viral disease rampages across the country and
sends hundreds of men, women and children to hospitals in Sri Lanka.The TAK-003 potential vaccine — which underwent testing in Sri Lanka
as part of a multi-centre clinical trial — was ‘efficacious& (successful in producing the desired effect) against
virologically-confirmed dengue fever (DF) among healthy children and adolescents 4-16 years of age, irrespective of previous dengue
exposure.Simply put, the potential vaccine which comes in the form of a two-dose subcutaneous injection, was &generally safe& and
It &demonstrated& protection in these children regardless of previous dengue exposure, it is understood.
